Inovio Pharmaceuticals Inc. Stock Advances 4.7%, Outperforms Peers
Dow Jones2026/09/01 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. rallied 4.7% to $1.33 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.
Inovio Pharmaceuticals Inc. closed 55.4% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.32% to $28.55.
Trading volume totaled 2.6 million, compared to the 50-day average of 3.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 01, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US President Donald Trump says was ready to strike Houthis in Yemen, then pulled back
ZAMA gains traction as 24h trading volume surges
Global economy risks fragmentation! Australia bets on AI as a new growth engine
In a potentially more fragmented and unpredictable global economy over the next 40 years, Australia relies on the deployment and development of artificial intelligence (AI) to drive economic growth.
Europe’s aviation fuel “red alert” in the fourth quarter: Shortfall will reach 510,000 barrels/day, South Korea’s exports surge to a four-year high to urgently fill the gap
According to analysts and shipping data, Europe will face a supply gap for aviation fuel in the fourth quarter, even as it turns to distant suppliers such as South Korea. South Korea's aviation fuel exports to Europe in September are set to reach a four-year high.
Crypto prices
More
